Source - SMW
Motif Bio has secured up to $20m in debt financing with Hercules Capital to fund preparation activities ahead of the US launch of iclaprim in 2019.

The first tranche of $15m will be drawn down immediately, with the remaining $5m available upon the achievement of certain milestones anticipated in 2018, the company said.


At 9:18am: (LON:MTFB) Motif Bio Plc Ord 1p share price was -0.62p at 36.13p



Related Charts

Motif Bio Ord 1p (MTFB)

-1.00p (-3.03%)
delayed 17:30PM